European public assessment reports

The European Medicines Agency (EMA) publishes a European public assessment report (EPAR) for every medicine granted a central marketing authorisation by the European Commission.

EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

EPARs also contain a public-friendly overview in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved:

As of October 2016, EMA publishes the clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure, allowing the public to better understand the Agency's decision-making. For more information see clinical data publication.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority:

For more information, see:

How useful was this page?

Add your rating
6 ratings
3 ratings
4 ratings
32 ratings